Access cutting-edge epidermolysis bullosa simplex treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access epidermolysis bullosa simplex specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epidermolysis bullosa simplex treatment provided free
This Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (4 years of age and older) diagnosed with generalized intermediate to severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) will be enrolled in the study and will be randomized to receive either TolaSure Gel or a topical Placebo for daily application for 2-months. After 2-months, all patients will receive TolaSure Gel to daily apply for an ad
Sponsor: BioMendics, LLC
Check if you qualify for this epidermolysis bullosa simplex clinical trial in Palo Alto, CA
If you're searching for epidermolysis bullosa simplex treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epidermolysis bullosa simplex specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.